The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Engineering Science
and Technology

The primary objective of the Engineering Science and Technology Program is to develop innovative technologies that will aid in the understanding, modeling, detection, and treatment of cancer. The following are some of the important research project areas ongoing in EST: implantable microdevices for continuous cancer monitoring, biocompatible quantum dots for imaging, new classes of materials for achieving RNA interference in vivo, formulations for coordinated temporal release of antioangiogenics and cytotoxic drugs, aptamer-targeted drug delivery in prostate cancer, gold nanorods for ablation, and microfluidic devices for measuring the physical properties of individual cancer cells.

Members:

Scott Manalis and Robert S. Langer, Program Leaders
Daniel G. Anderson
Regina Barzilay
Angela Belcher
Sangeeta N. Bhatia
Paul Blainey
Michael Cima
Patrick Doyle
Elazer Edelman
Linda G. Griffith
Paula T. Hammond
Jeremiah Johnson
Amy Keating
Tim Lu
Bradley Pentelute
Ram Sasisekharan
Alex Shalek